Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The most recent insider filings available from ORTEX cover trades reported on 8 September 2026. The data skews heavily toward non-US markets, as the SEC EDGAR tables required for US open-market trades were unavailable in this environment.
The single largest disclosed transaction was JPMorgan Chase acquiring a stake worth $737M in Cathay Pacific Airways, filed on 8 September. The bank also reduced positions in Kingdee International Software and Sunny Optical Technology, with sales of $85M and $71M respectively, both on 2 September.
Selling pressure was also visible in India. Fosun Pharma Industrial offloaded two tranches of Gland Pharma shares totalling nearly $297M across early September, a significant reduction by the Chinese pharma group in its Indian subsidiary.
In Korea, ROBOTIS CEO Kim Byeong Soo filed a $75M sale of ROBOTIS shares on 8 September. That is a large discretionary disposal by a founder-CEO and warrants attention, though all figures here carry the caveat that stakes are as last disclosed.
Italian cosmetics supplier Intercos saw private equity backer L Catterton sell $94M of stock on 2 September, a typical PE exit move rather than a management signal.
All trades shown carry trade significance scores of 1 to 3, the lower end of the ORTEX scale. No high-conviction open-market purchases above $1M by C-suite executives were recorded in the period covered. US insider data from SEC EDGAR Form 4 filings could not be retrieved in this session.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
